Kalhan, R., Slade, D., Ray, R., Moretz, C., Germain, G., Laliberté, F., . . . Hahn, B. (2021). Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities. Int J Chron Obstruct Pulmon Dis.
Stile di citazione ChicagoKalhan, Ravi, et al. "Umeclidinium/Vilanterol Compared With Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium As Initial Maintenance Therapy in Patients With COPD Who Have High Costs and Comorbidities." Int J Chron Obstruct Pulmon Dis 2021.
Citazione MLAKalhan, Ravi, et al. "Umeclidinium/Vilanterol Compared With Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium As Initial Maintenance Therapy in Patients With COPD Who Have High Costs and Comorbidities." Int J Chron Obstruct Pulmon Dis 2021.